HC Wainwright & Co. Maintains Buy on I-MAB, Lowers Price Target to $18
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Andrew Fein maintains a 'Buy' rating on I-MAB (NASDAQ:IMAB), but has lowered the price target from $25 to $18.
August 18, 2023 | 12:44 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
The 'Buy' rating for I-MAB is maintained by HC Wainwright & Co., but the price target is lowered from $25 to $18.
The lowering of the price target by HC Wainwright & Co. could potentially lead to a short-term negative impact on I-MAB's stock price. However, the maintained 'Buy' rating indicates the analyst's continued confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100